Clinical Trials Browser

Phase 1/2 × Not yet recruiting × Carcinoma, Transitional Cell × Clear all

NCT07421700 2026-02-19

A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Phase 1/2 Not yet recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell